MedElevator Войти в исследования
← Поиск публикаций

DOI 10.22037/ghfbb.v17i2.2903

Медицинская библиотека · Gastroenterology and hepatology from bed to bench · 2024

Efficacy and safety of alpha-pinene capsule in the management of functional dyspepsia and eradication of helicobacter pylori: a randomized clinical trial.

Abdi Saeed, Abazarikia Ali, Mojab Faraz, Zahedi Alireza, Moghtaderi Mina, Mortazavi Elham, Naseri Veria, Haghazali Mehrdad, Rabbani Amir Hassan, Abbasinazari Mohammad

СтатьяПеревод пока не подготовлен

Аннотация

AIM: Our objective was to assess the efficacy and safety of adding alpha-pinene (a herbal terpenoid) to quadruple therapy compared to a placebo in improving symptoms and Helicobacter pylori (H. pylori) eradication rates in Functional dyspepsia (FD) patients.

BACKGROUND

FD is a prevalent upper gastrointestinal condition, and no definitive pharmacological treatment is available for its management.

METHODS

We conducted a randomized, double-blinded, placebo-controlled trial on FD patients diagnosed with H. pylori infection. We collected baseline demographic data and assessed FD symptoms in the participants. Patients were randomly allocated to receive either standard quadruple therapy with α-pinene capsules (0.25 mg/day) or quadruple therapy with a placebo for two weeks. We employed a validated questionnaire, the Short Form Leeds Dyspepsia Questionnaire (SF-LDQ), to evaluate FD symptoms. The eradication rate of H. pylori was compared between the two groups one month after completing the treatment regimens. Any reported adverse drug reactions (ADRs) were documented throughout the trial.

RESULTS

Over four months, a total of 66 patients completed the trial. Notably, there were no significant differences in baseline SF-LDQ scores between the two groups (p=0.83); however, a significant divergence emerged at the trial's conclusion (p=0.03). The H. pylori eradication rates did not show notable differences between the two treatment arms (p=0.43). Importantly, there were no dropouts from the trial due to ADRs. Among reported ADRs, participants experienced abdominal pain, headache, diarrhea, and a metallic taste, with no significant variance in incidence rates observed between the two groups (p=0.62).

CONCLUSION

These findings suggest that α-pinene could be an effective and safe agent for reducing FD symptoms.

Для цитирования: Abdi Saeed, Abazarikia Ali, Mojab Faraz, Zahedi Alireza, Moghtaderi Mina, Mortazavi Elham, Naseri Veria, Haghazali Mehrdad, Rabbani Amir Hassan, Abbasinazari Mohammad. Efficacy and safety of alpha-pinene capsule in the management of functional dyspepsia and eradication of helicobacter pylori: a randomized clinical trial.. Gastroenterology and hepatology from bed to bench. 2024. DOI: 10.22037/ghfbb.v17i2.2903.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.